| Date Filed | Type | Description |
| 03/20/2023 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 1,835 shares
@ $8.27, valued at
$15.2k
Paid exercise price by delivering 934 shares
@ $8.27, valued at
$7.7k
Exercised 5,900 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0
Granted 64,000 options to buy
@ $8.27, valued at
$529.3k
Granted 46,300 restricted stock units
@ $0 |
|
| 12/29/2022 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 187 shares
@ $9.44, valued at
$1.8k
Exercised 750 restricted stock units
@ $0 |
|
| 12/28/2022 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 10,784 shares
@ $9.44, valued at
$101.8k
Exercised 20,000 options to buy
@ $5.09, valued at
$101.8k
|
|
| 07/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 1,181 shares
@ $0
Paid exercise price by delivering 357 shares
@ $8.42, valued at
$3k
|
|
| 12/29/2021 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 187 shares
@ $9.74, valued at
$1.8k
Exercised 750 restricted stock units
@ $0 |
|
| 12/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2021 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 1,580 shares
@ $0
Paid exercise price by delivering 392 shares
@ $19.2, valued at
$7.5k
|
|
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/30/2020 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 1,500 shares
@ $0
Sold 371 shares
@ $17.81, valued at
$6.6k
|
|
| 12/22/2020 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.|
Txns:
| Granted 575 shares
@ $0
Sold 147 shares
@ $16.42, valued at
$2.4k
|
|
| 12/17/2020 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 4,373 shares
@ $16.5, valued at
$72.2k
Exercised 15,000 options to buy
@ $4.81, valued at
$72.2k
|
|
| 04/29/2020 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 2,530 options to buy
@ $0.27, valued at
$683.1 |
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/31/2018 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Granted 11,900 options to buy
@ $19.17, valued at
$228.1k
Granted 3,000 restricted stock units
@ $0 |
|
| 11/15/2018 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Paid exercise price by delivering 2,882 shares
@ $33.28, valued at
$95.9k
Exercised 35,000 options to buy
@ $2.74, valued at
$95.9k
Exercised 274 options to buy
@ $0.27, valued at
$74 |
|
| 12/20/2017 |
4
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Granted 13,900 options to buy
@ $27, valued at
$375.3k
Granted 2,300 restricted stock units
@ $0 |
|
| 03/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2016 |
4/A
| DeVinney Erick Wayne (VP, Clinical&Translational Sc) has filed a Form 4 on AxoGen, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.09, valued at
$101.8k
|
|